Two Sigma Advisers’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Sell |
|
|||||
|
2025
Q1 | $4.95M | Buy |
|
|||||
|
2024
Q4 | $1.18M | Sell |
|
|||||
|
2024
Q3 | $5.56M | Sell |
|
|||||
|
2024
Q2 | $6.87M | Sell |
|
|||||
|
2024
Q1 | $11.8M | Sell |
|
|||||
|
2023
Q4 | $9.45M | Sell |
|
|||||
|
2023
Q3 | $17.3M | Sell |
|
|||||
|
2023
Q2 | $30.8M | Buy |
|
|||||
|
2023
Q1 | $21.1M | Buy |
|
|||||
|
2022
Q4 | $16.1M | Buy |
|
|||||
|
2022
Q3 | $11.7M | Buy |
|
|||||
|
2022
Q2 | $8.31M | Buy |
|
|||||
|
2022
Q1 | $4.11M | Buy |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $275K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.05M | Buy |
|
|||||
|
2020
Q4 | $1.6M | Buy |
|